{"entity":{"id":"jilin-cancer-hospital","kind":"institution","name":"Jilin Cancer Hospital","aka":["吉林省肿瘤医院"],"tldr":"Jilin Cancer Hospital in Changchun is the centre that led China's small cell lung cancer immunotherapy trials, including ASTRUM-005 and CAPSTONE-1.","summary":"Provincial cancer centre whose thoracic oncology department under Cheng Ying has been principal investigator for serplulimab (ASTRUM-005), adebrelimab (CAPSTONE-1), benmelstobart plus anlotinib and other extensive-stage SCLC trials, making a north-eastern provincial hospital one of the most cited sites in the disease.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.jlszlyy.com/"}],"tags":["china"],"related":[],"cancers":["sclc"],"sections":[],"technologies":[],"targets":[],"drugs":["serplulimab","adebrelimab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["astrum-005","capstone-1"],"people":["cheng-ying"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Changchun","country":"CN","lat":43.88,"lng":125.323,"institutionType":"cancer-center","website":"https://www.jlszlyy.com/","programs":["Small cell lung cancer trials","Thoracic oncology"]},"route":"/institutions/jilin-cancer-hospital/","neighbours":{"cancer":[{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"adebrelimab","kind":"drug","name":"Adebrelimab","route":"/drugs/adebrelimab/"},{"id":"serplulimab","kind":"drug","name":"Serplulimab","route":"/drugs/serplulimab/"}],"trial":[{"id":"astrum-005","kind":"trial","name":"ASTRUM-005","route":"/trials/astrum-005/"},{"id":"capstone-1","kind":"trial","name":"CAPSTONE-1","route":"/trials/capstone-1/"}],"person":[{"id":"cheng-ying","kind":"person","name":"Ying Cheng","route":"/people/cheng-ying/"}]}}